Why This Complication Is Easy to Miss
Normally, doctors and patients watch for high blood sugar and classic diabetic ketoacidosis symptoms as red flags. Euglycemic ketoacidosis breaks that pattern: it produces the same dangerous acid buildup and ketone levels in the blood, but blood sugar stays normal or only slightly elevated, which can delay diagnosis if a doctor isn’t specifically looking for it. The mechanism appears to involve the combination of a GLP-1 or GIP/GLP-1 drug’s strong appetite suppression and delayed stomach emptying with inadequate calorie or carbohydrate intake — in effect, a kind of masked starvation response, where the body starts breaking down fat for energy and producing ketones, even though blood sugar readings look reassuring.
FindTreatmentsThe Case Reports Behind This Warning
The editorial specifically cites three Japanese cases: young women aged 21 to 23, none with diabetes and two not classified as obese, hospitalized with ketosis or ketoacidosis after using tirzepatide inappropriately — in two cases, the reaction occurred at the lowest starting dose. The authors note that many of these cases involved people acquiring the medication, prescribed and reimbursed in Japan specifically for type 2 diabetes, through unofficial channels for cosmetic weight loss instead, sometimes combined with aggressive dieting on top of the drug’s own appetite-suppressing effects.
TAKING A STATIN OR BLOOD PRESSURE MEDICATION?Your numbers look better. So why do you still feel tired, foggy, or off?
